# Aurinia Pharmaceuticals Inc.: Form 8-K, filed Nov 7, 2024

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: 8-K
- Filed: 2024-11-07
- Accepted by EDGAR: Nov 7, 2024, 06:13 ET
- Period: 2024-11-07
- Accession: 0001600620-24-000106
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000160062024000106/auph-20241107.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000160062024000106/

## Items reported

- Item 2.02: Results of operations
- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000160062024000106/auph-20241107.htm

Filed Nov 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001600620-24-000106. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.